Tags

Type your tag names separated by a space and hit enter

Laboratory Assessment of Diabetic Kidney Disease.

Abstract

IN BRIEF Regardless of etiology, chronic kidney disease (CKD) is identified by two laboratory tests: 1) estimated glomerular filtration rate (eGFR), a measure of kidney function, and 2) urine albumin-to-creatinine ratio (UACR), a measure of kidney damage. It is crucial for all health professionals to understand the significance and limitations of these tests to appropriately identify CKD patients, guide therapy, and determine prognosis. This article provides information that will enable diabetes educators and other clinicians to properly interpret eGFR and UACR laboratory results in the identification and management of CKD.

Links

  • PMC Free PDF
  • PMC Free Full Text
  • Authors+Show Affiliations

    ,

    National Kidney Disease Education Program, National Institutes of Health, Bethesda, MD.

    Newcastle University, Newcastle upon Tyne, United Kingdom.

    Source

    Pub Type(s)

    Journal Article

    Language

    eng

    PubMed ID

    26300608

    Citation

    Narva, Andrew S., and Rudolf W. Bilous. "Laboratory Assessment of Diabetic Kidney Disease." Diabetes Spectrum : a Publication of the American Diabetes Association, vol. 28, no. 3, 2015, pp. 162-6.
    Narva AS, Bilous RW. Laboratory Assessment of Diabetic Kidney Disease. Diabetes Spectr. 2015;28(3):162-6.
    Narva, A. S., & Bilous, R. W. (2015). Laboratory Assessment of Diabetic Kidney Disease. Diabetes Spectrum : a Publication of the American Diabetes Association, 28(3), pp. 162-6. doi:10.2337/diaspect.28.3.162.
    Narva AS, Bilous RW. Laboratory Assessment of Diabetic Kidney Disease. Diabetes Spectr. 2015;28(3):162-6. PubMed PMID: 26300608.
    * Article titles in AMA citation format should be in sentence-case
    TY - JOUR T1 - Laboratory Assessment of Diabetic Kidney Disease. AU - Narva,Andrew S, AU - Bilous,Rudolf W, PY - 2015/8/25/entrez PY - 2015/8/25/pubmed PY - 2015/8/25/medline SP - 162 EP - 6 JF - Diabetes spectrum : a publication of the American Diabetes Association JO - Diabetes Spectr VL - 28 IS - 3 N2 - IN BRIEF Regardless of etiology, chronic kidney disease (CKD) is identified by two laboratory tests: 1) estimated glomerular filtration rate (eGFR), a measure of kidney function, and 2) urine albumin-to-creatinine ratio (UACR), a measure of kidney damage. It is crucial for all health professionals to understand the significance and limitations of these tests to appropriately identify CKD patients, guide therapy, and determine prognosis. This article provides information that will enable diabetes educators and other clinicians to properly interpret eGFR and UACR laboratory results in the identification and management of CKD. SN - 1040-9165 UR - https://www.unboundmedicine.com/medline/citation/26300608/full_citation L2 - https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/26300608/ DB - PRIME DP - Unbound Medicine ER -